A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma

Molecular and Cellular Biology

Volumn 16, Issue 7, 1996, Pages 3480-3489

  Knaus, Petra I ^a   Lindemann, Dirk ^a   DeCoteau, John F ^b   Perlman, Riki ^a   Yankelev, Haya ^a   Hille, Merrill ^a,d   Kadin, Marshall E ^b   Lodish, Harvey F ^a,c  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; RNA; TETRACYCLINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ALLELE; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CERCOPITHECIDAE; GENE; GENE MUTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MUTANT; NONHUMAN; NORTHERN BLOTTING; POINT MUTATION; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0029938791     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.16.7.3480     Document Type: Article

References (51)

1. Aruffo, A., and B. Seed. 1987. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA 84:8573-8577.
2. Brand, T., W. R. MacLellan, and M. D. Schneider. 1993. A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. J. Biol. Chem. 268:11500-11503.
3. Brand, T., and M. D. Schneider. 1995. Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF beta-dependent transcription. J. Biol. Chem. 270:8274-8284.
4. Capocasale, R. J., R. J. Lamb, E. C. Vonderheid, F. E. Fox, A. H. Rook, P. C. Nowell, and J. S. Moore. 1995. Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sczary patients. Proc. Natl. Acad. Sci. USA 92:5501-5505.
5. Carcamo, J., F. M. Weis, F. Ventura, R. Wieser, J. L. Wrana, L. Attisano, and J. Massague. 1994. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol. Cell. Biol. 14:3810-3821.
6. Chen, F., and R. A. Weinberg. 1995. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor B receptor kinases. Proc. Natl. Acad. Sci. USA 92:1565-1569.
7. Filmus, J., and R. S. Kerbel. 1993. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression. Curr. Opin. Oncol. 5:123-129.
8. Franzen, P., P. ten Dijke, H. Ichijo, H. Yamashita, P. Schulz, C. H. Heldin, and K. Miyazono. 1993. Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75:681-692.
9. Friend, S. H., T. P. Dryja, and R. A. Weinberg. 1988. Oncogenes and tumor-suppressing genes. N. Engl. J. Med. 318:618-622.
10. Geiser, A. G., J. K. Burmester, R. Webbink, A. B. Roberts, and M. B. Sporn. 1992. Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses. J. Biol. Chem. 267:2588-2593.
11. Gossen, M., A. L. Bonin, and H. Bujard. 1993. Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem. Sci. 18:471-475.
12. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
13. Henis, Y. I., A. Moustakas, H. Y. Lin, and H. F. Lodish. 1994. The types II and III transforming growth factor-beta receptors form homo-oligomers. J. Cell Biol. 126:139-154.
14. Hinds, P. W., and R. A. Weinberg. 1994. Tumor suppressor genes. Curr. Opin. Genet. Dev. 4:135-141.
15. Hoosein, N. M., M. K. McKnight, A. E. Levine, K. M. Mulder, K. E. Childress, D. E. Brattain, and M. G. Brattain. 1989. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. Exp. Cell Res. 181:442-453.
16. Inagaki, M., A. Moustakas, H. Y. Lin, H. F. Lodish, and B. I. Carr. 1993. Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA. Proc. Natl. Acad. Sci. USA 90:5359-5363.
17. Ionov, Y., M. A. Peinado, S. Malkhosyan, D. Shibata, and M. Perucho. 1993. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (London) 363:558-561.
18. Kadin, M. E., M. W. Cavaille-Coll, R. Gertz, J. Massague, S. Cheifetz, and D. George. 1994. Loss of receptors for transforming growth factor beta in human T-cell malignancies. Proc. Natl. Acad. Sci. USA 91:6002-6006.
19. Kashles, O., Y. Yarden, R. Fischer, A. Ullrich, and J. Schlessinger. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell. Biol. 11:1454-1463.
20. Killary, A. M., M. E. Wolf, T. A. Giambernardi, and S. L. Naylor. 1992. Definition of a tumor suppressor locus within human chromosome 3p21-p22. Proc. Natl. Acad. Sci. USA 89:10877-10881.
21. Kimchi, A., X. F. Wang, R. A. Weinberg, S. Cheifetz, and J. Massague. 1988. Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells. Science 240:196-199.
22. Knighton, D. R., J. H. Zheng, L. F. Ten Eyck, V. A. Ashford, N. H. Xuong, S. S. Taylor, and J. M. Sowadski. 1991. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253:407-414.
23. Levine, A. J., J. Momand, and C. A. Finlay. 1991. The p53 tumour suppressor gene. Nature (London) 351:453-456.
24. Lin, H. Y., A. Moustakas, P. Knaus, R. G. Wells, V. I. Henis, and H. F. Lodish. 1995. The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands. J. Biol. Chem. 270:2747-2754.
25. Lin, H. Y., X. F. Wang, E. Ng-Eaton, R. A. Weinberg, and H. F. Lodish. 1992. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785. (Erratum, 70:following 1068.)
26. Lindemann, D., and K. Mulligan. Unpublished data.
27. Manning, A. M., A. C. Williams, S. M. Game, and C. Paraskeva. 1991. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigcnic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Oncogene 6:1471-1476.
28. Markowitz, S., J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R. S. Fan, E. Zborowska, K. W. Kinzler, B. Vogelstein, M. Brattain, and J. K. V. Willson. 1995. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338.
29. Massague, J. 1990. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6:597-641.
30. Mathew, S., V. V. Murty, S. Cheifetz, D. George, J. Massague, and R. S. Chaganti. 1994. Transforming growth factor receptor gene TGFBR2 maps to human chromosome hand 3p22. Genomics 20:114-115.
31. Malhews, L. S., and W. W. Vale. 1991. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65:973-982.
32. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-982.
33. Moses, H. L., E. Y. Yang, and J. A. Pietenpol. 1990. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245-247.
34. Moustakas, A., H. Y. Lin, Y. I. Henis, J. Plamondon, M. D. O'Connor-McCourt, and H. F. Lodish. 1993. The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand. J. Biol. Chem. 268:22215-22218.
35. Park, K., S. J. Kim, Y. J. Bang, J. G. Park, N. K. Kim, A. B. Roberts, and M. B. Sporn. 1994. Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc. Natl. Acad. Sci. USA 91:8772-8776.
36. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
37. Rodriguez, C., F. Chen, R. A. Weinberg, and H. F. Lodish. 1995. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors. J. Biol. Chem. 270:15919-15922.
38. Tan, J. C., K. Nocka, P. Ray, P. Traktman, and P. Besmer. 1990. The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247:209-212.
39. ten Dijke, P., H. Yamashita, T. K. Sampath, A. H. Reddi, M. Estevez, D. L. Riddle, H. Ichijo, C. H. Heldin, and K. Miyazono. 1994. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269:16985-16988.
40. Ueno, H., H. Colbert, J. A. Escobedo, and L. T. Williams. 1991. Inhibition of PDGF beta receptor signal transduction by coexpression of a truncated receptor. Science 252:844-848.
41. Ueno, H., M. Gunn, K. Dell, A. Tseng, Jr., and L. Williams. 1992. A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J. Biol. Chem. 267:1470-1476.
42. Wang, X. F., H. Y. Lin, E. Ng-Eaton, J. Downward, H. F. Lodish, and R. A. Weinberg. 1991. Expression cloning and characterization of the TGF-beta type III receptor. Cell 67:797-805.
43. Watowich, S. S., D. J. Hilton, and H. F. Lodish. 1994. Activation and inhibition of erythropoietin receptor function: role of receptor dimerization. Mol. Cell. Biol. 14:3535-3549.
44. Weinberg, R. 1993. Tumor suppressor genes. Neuron 11:191-196.
45. 44a.Wells, R., and H. Lodish. Unpublished data.
46. Wilson, I. A., H. L. Niman, R. A. Houghten, A. R. Cherenson, M. L. Connolly, and R. A. Lerner. 1984. The structure of an antigenic determinant in a protein. Cell 37:767-778.
47. Wrana, J. L., L. Attisano, R. Wieser, F. Ventura, and J. Massague. 1994. Mechanism of activation of the TGF-beta receptor. Nature (London) 370:341-347.
48. Wrana, J. L., L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X. F. Wang, and J. Massague. 1992. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71:1003-1014.
49. Wu, S. P., D. Theodorescu, R. S. Kerbel, J. K. Willson, K. M. Mulder, L. E. Humphrey, and M. G. Brattain. 1992. TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J. Cell Biol. 116:187-196.
50. Yamakawa, K., T. Takahashi, Y. Horio, Y. Murata, E. Takahashi, K. Hibi, S. Yokoyama, R. Ueda, T. Takahashi, and Y. Nakamura. 1993. Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22. Oncogene 8:327-330.
51. Yamashita, H., P. ten Dijke, P. Franzen, K. Miyazono, and C. H. Heldin. 1994. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. J. Biol. Chem. 269:20172-20178.